Tempest Tx (TPST): Balans kapitallashuviga qarzlar

Tempest Therapeutics Inc (TPST) grafik logotipi

Ma'lumotlar tahlilini avtomatlashtirish dori vositalarini ishlab chiqishni tezlashtiradi, buni qarzning kitob qiymatiga nisbati dinamikasi isbotlaydi; 0.00 eng so'nggi daraja qiymatini ifodalaydi. O'sish modeli tadqiqot va ishlanmalarni (R&D) saqlab qolgan holda, savdoni hamkorlarga o'tkazishga asoslangan. Immunoterapiya molekulalarining noyobligi tasdiqlangandan so'ng premium narxlarni ta'minlaydi, garchi hozirda Tempest Therapeutics (TPST) uchun narx belgilash imkoniyati sinov natijalari bilan cheklangan bo'lsa-da.

Tempest Therapeutics (TPST) - Balans qiymatiga qarzlar 04.07.2022dan 27.10.2026gacha

Tempest Therapeutics Inc (TPST) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Tempest Therapeutics|TPST - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Tempest Therapeutics Corp|TPST - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Tempest Therapeutics|TPST - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati tempesttx.com|TPST - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Tempest Therapeutics|TPST - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Tempest Tx|TPST - Kompaniyaning umumiy qarzi|Qarzning balans qiymatiga nisbati Tempest Therapeutics Corp
Kompaniyaning barcha koʻrsatkichlari tahlili:Tempest Therapeutics TPST
Tempest Therapeutics Inc asosiy tovari

Tempest Therapeutics (TPST) ishlab chiqarish va sinovlarni uchinchi tomon pudratchilariga topshirish orqali kapital xarajatlarini minimallashtiradi. Qarzning kapitalga nisbati va majburiyatlar koeffitsiyenti biznesning kreditorlarga qanchalik bog'liqligini ochib beradi. Moliyaviy tuzilmaning, xususan, qarzning kitob qiymatidagi kapitalizatsiyasining tahlili moliyaviy mustaqillikning joriy darajasini ko'rsatadi. Ushbu koeffitsiyentning pasayishi kompaniyaning bozor zarbalariga chidamliligini tasdiqlaydi va investorlar past qiymatlarni defoltga qarshi himoya deb talqin qiladilar.

Tempest Therapeutics kimlar bilan raqobatlashadi

ONC - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati halozyme.com HALO|RVMD: Balans kapitallashuviga qarzlar|AAPG - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CGON|URGN (UroGen Pharma Corp) - Balans qiymatiga qarzlar|BCAX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati personalis.com (PSNL)|Erasca (ERAS) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Delcath Systems Inc (DCTH)|YmAbs - Balans kapitallashuviga qarzlar|AURA - Qarzning balans qiymatiga nisbati|Candel - Qarzning balans qiymatiga nisbati|ARAY: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati sellaslifesciences.com SLS|Actuate Therapeutics Inc. (ACTU) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar CTOR (Citius Oncology, Inc)|Balans qiymatiga qarzlar TuHURA (HURA)|Qarzning balans qiymatiga nisbati Protara Therapeutics|Qarzning balans kapitaliga nisbati fatetherapeutics.com (FATE)|WHWK: Balans kapitallashuviga qarzlar|TScan Therapeutics Inc - Balans qiymatiga qarzlar|CSBR: Qarzning balans kapitallashuviga nisbati|XBIT: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati cel-sci.com (CVM)|ostherapies.com (OSTX) - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar RADX (Radiopharm Theranostics Limited)|Balans qiymatiga qarzlar ARTV|ANL (Adlai Nortye Ltd.) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Veru Corporation VERU|Qarzning balans qiymatiga nisbati Xilio Therapeutics (XLO)|RENB - Qarzning balans kapitaliga nisbati|Qarzning balans qiymatiga nisbati Mural Bio (MURA)|Kairos Pharma Ltd (KAPA) - Qarzning sof aktivlarga nisbati|OKUR - Qarzning balans qiymatiga nisbati|CytoMed Therapeutics Limited (GDTC) - Qarzning balans kapitaliga nisbati|CRIS - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Apollomics Corp|Tharimmune - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar ADVB (advanbiomed.com)|Qarzning balans kapitallashuviga nisbati Genprex, Inc|Qarzning sof aktivlarga nisbati Calidi Biotherapeutics Inc. CLDI|Sunshine Biopharma, Inc. - Balans kapitallashuviga qarzlar|XBIO: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Salarius Pharmaceuticals, Inc. (SLRX)|Purple Biotech Ltd (PPBT) - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar AONC (American Oncology Network Inc)|Balans qiymatiga qarzlar BeiGene Ltd (BGNE)|Qarzning balans qiymatiga nisbati CKPT|Balans kapitallashuviga qarzlar elevationoncology.com ELEV|Qarzning balans qiymatiga nisbati iCAD (ICAD)|Qarzning balans kapitaliga nisbati Ikena Oncology Inc. IKNA|Balans kapitallashuviga qarzlar NTBL (Notable Labs Inc.)|VIRX - Sof aktivlarga qarzlar|MOR (MorphoSys AG) - Balans kapitallashuviga qarzlar|NAYA (nayabiosciences.com) - Qarzning balans qiymatiga nisbati|AAPGV: Qarzning balans kapitallashuviga nisbati